HCNC
🇧🇪Belgium
- Country
- 🇧🇪Belgium
- Ownership
- Private, Subsidiary
- Established
- 1977-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.uzbrussel.be
Evaluation of 68-GaNOTA-Anti-HER2 VHH1 Uptake in Brain Metastasis of Cancer Patients
Phase 2
Recruiting
- Conditions
- First Posted Date
- 2017-11-06
- Last Posted Date
- 2024-04-24
- Lead Sponsor
- Universitair Ziekenhuis Brussel
- Target Recruit Count
- 30
- Registration Number
- NCT03331601
- Locations
- 🇧🇪
Uz Brussel, Brussels, Belgium
Characterizing Sleep Disorders in Children and Adults With Tuberous Sclerosis Complex (TSC)
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2017-10-31
- Last Posted Date
- 2018-10-17
- Lead Sponsor
- Universitair Ziekenhuis Brussel
- Target Recruit Count
- 60
- Registration Number
- NCT03326765
- Locations
- 🇧🇪
Universitair Ziekenhuis Brussel, Jette, Vlaams Brabant, Belgium
Effect of Abstinence Duration on Embryo Development
- First Posted Date
- 2017-10-27
- Last Posted Date
- 2023-01-23
- Lead Sponsor
- Universitair Ziekenhuis Brussel
- Target Recruit Count
- 100
- Registration Number
- NCT03323892
- Locations
- 🇧🇪
Universitair Ziekenhuis Brussel, Brussels, Belgium
Plasma CO2 Removal Due to CRRT and Its Influence on Indirect Calorimetry
Not Applicable
Completed
- Conditions
- Interventions
- Diagnostic Test: blood gas analysis under citrate predilutionDevice: filter replacementDevice: ICDrug: NaCl predilutionDiagnostic Test: blood gas analysis under NaCl predilutionDrug: double ultrafiltrationDiagnostic Test: blood gas analysis under citrate predilution and double ultrafiltration rateDietary Supplement: pause and restart nutritional therapyDiagnostic Test: evolution of vitamin and trace elements
- First Posted Date
- 2017-10-19
- Last Posted Date
- 2022-05-18
- Lead Sponsor
- Universitair Ziekenhuis Brussel
- Target Recruit Count
- 10
- Registration Number
- NCT03314363
- Locations
- 🇧🇪
universitair ziekenhuis Brussel, Brussels, Belgium
Baclofen in Managing Acute Alcohol Withdrawal
Phase 4
- Conditions
- Interventions
- First Posted Date
- 2017-09-26
- Last Posted Date
- 2021-11-04
- Lead Sponsor
- Universitair Ziekenhuis Brussel
- Target Recruit Count
- 90
- Registration Number
- NCT03293017
- Locations
- 🇧🇪
University Hospital Brussels, Brussels, Belgium
Clinical Trial on the Combination of Avelumab and Axitinib for the Treatment of Patients With Recurrent Glioblastoma
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-09-25
- Last Posted Date
- 2019-01-23
- Lead Sponsor
- Universitair Ziekenhuis Brussel
- Target Recruit Count
- 52
- Registration Number
- NCT03291314
- Locations
- 🇧🇪
UZ Brussel, Brussel, Belgium
Intra-tumoral Ipilimumab Plus Intravenous Nivolumab Following the Resection of Recurrent Glioblastoma
Phase 1
- Conditions
- Interventions
- First Posted Date
- 2017-07-28
- Last Posted Date
- 2023-10-11
- Lead Sponsor
- Universitair Ziekenhuis Brussel
- Target Recruit Count
- 110
- Registration Number
- NCT03233152
- Locations
- 🇧🇪
Universitair Ziekenhuis Brussel, Brussels, Belgium
N-acetylcysteine for the Treatment of Cannabis Dependence: Working Mechanisms
- First Posted Date
- 2017-07-18
- Last Posted Date
- 2020-12-08
- Lead Sponsor
- Universitair Ziekenhuis Brussel
- Target Recruit Count
- 75
- Registration Number
- NCT03221231
- Locations
- 🇧🇪
University Hospital Brussels, Brussels, Belgium
Optimisation of Follicular Recruitment in IVM Cycles
- First Posted Date
- 2017-06-23
- Last Posted Date
- 2023-04-07
- Lead Sponsor
- Universitair Ziekenhuis Brussel
- Target Recruit Count
- 145
- Registration Number
- NCT03197077
- Locations
- 🇧🇪
UZ Brussel, Brussels, Belgium
Maximal Effort-dependent Respiratory Flow Rates
- Conditions
- First Posted Date
- 2017-06-23
- Last Posted Date
- 2017-07-18
- Lead Sponsor
- Universitair Ziekenhuis Brussel
- Target Recruit Count
- 300
- Registration Number
- NCT03197701
- Locations
- 🇧🇪
UZ Brussel, Brussels, Belgium
© Copyright 2024. All Rights Reserved by MedPath